Depression and anxiety were each associated with a higher risk of major adverse cardiac events, with the greatest risk observed when both conditions co-occurred, and these associations were partly mediated by heightened stress-related neural activity and downstream autonomic and inflammatory dysregulation. In more than 85,000 participants from the Mass General Brigham Biobank (2010–2020) followed for a median of 3.4 years, depression increased the risk of major adverse cardiac events (hazard ratio, 1.24), an effect that was stronger for individuals with concurrent anxiety and depression (hazard ratio, 1.35) and remained significant after extensive adjustment for confounders. In subgroups with imaging and biomarker data, depression and anxiety were linked to higher amygdala-to-prefrontal cortex activity, reduced heart rate variability, and elevated C-reactive protein levels, all markers of stress-related autonomic and immune activation. Mediation analyses confirmed that these neural and physiological pathways partially explained the relationship between depression, anxiety and cardiac risk, highlighting shared stress-related mechanisms. Source: https://www.ahajournals.org/
Long-term follow-up of two randomized lifestyle intervention trials found that reducing visceral fat—not simply losing…
Recently identified brain rhythm during sleep may play a crucial role in clearing neurotoxic waste…
A US community-based study found that middle-aged adults with blood biomarkers indicating Alzheimer’s disease neuropathology…
A randomized clinical trial found that a single 25 mg dose of psilocybin produced rapid…
The American Cancer Society (ACS) reaffirmed that average-risk adults should begin colorectal cancer (CRC) screening…
A comprehensive systematic review and meta-analysis involving 69 randomized controlled trials and 153,902 adults found…
This website uses cookies.